Regulatory PathRegulatory requirements compared

Active substance

Pancuronium

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ALPAX AMP. 2MG-ML2 mg/mlSolution · Intravenous use6 AmpouleSAR 13.40Generic · PrescriptionHikma Pharmaceuticals PLCValid
PAVULON 2MG-ML INJ 2ML2 mg/mlInjection · Intravenous use50 AmpouleSAR 292.05NCE · PrescriptionORGANONWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

ANESTHESIA

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
PANCURONIUM BROMIDE1MG/MLinjectable · injectionDR REDDYSPrescription31 Jul 1990
PANCURONIUM BROMIDE2MG/MLinjectable · injectionDR REDDYSPrescription31 Jul 1990
PAVULON2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionORGANON USA INCDiscontinued24 Oct 1972
PANCURONIUM BROMIDE1MG/MLinjectable · injectionELKINS SINNDiscontinued23 Mar 1988
PANCURONIUM BROMIDE2MG/MLinjectable · injectionELKINS SINNDiscontinued23 Mar 1988
PANCURONIUM BROMIDE2MG/MLinjectable · injectionELKINS SINNDiscontinued23 Mar 1988
PANCURONIUM BROMIDE1MG/MLinjectable · injectionHOSPIRADiscontinued19 Jan 1989
PANCURONIUM BROMIDE2MG/MLinjectable · injectionHOSPIRADiscontinued19 Jan 1989
PANCURONIUM BROMIDE2MG/MLinjectable · injectionQUAD PHARMSDiscontinued
PANCURONIUM BROMIDE1MG/MLinjectable · injectionQUAD PHARMSDiscontinued
PANCURONIUM BROMIDE1MG/MLinjectable · injectionIGI LABS INCDiscontinued
PANCURONIUM BROMIDE2MG/MLinjectable · injectionIGI LABS INCDiscontinued
PANCURONIUM BROMIDE2MG/MLinjectable · injectionIGI LABS INCDiscontinued
PANCURONIUM BROMIDE2MG/MLinjectable · injectionIGI LABS INCDiscontinued

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.